[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369072-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369072-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","co-infections-and-reactivation-of-some-herpesviruses-hhv-and-measles-virus-mev-in-egyptian-cancer-patients-infected-with-severe-acute-respiratory-syndrome-coronavirus-2-sars-cov-2","Co-infections and Reactivation of some Herpesviruses (HHV) and Measles Virus (MeV) in Egyptian Cancer Patients infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)","","Coinfections and reactivation of persistent or latent viruses, including herpesviruses (HHV) and measles virus (MeV), have been reported in COVID-19 patients, but evidence in cancer patients remained limited. This prospective observational study assessed the interplay between SARS-CoV-2, HHV, and MeV in newly diagnosed cancer patients and matched controls using qRT-PCR for SARS-CoV-2 and ELISA for viral antibody reactivation patterns.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/co-infections-and-reactivation-of-some-herpesviruses-hhv-and-measles-virus-mev-in-egyptian-cancer-patients-infected-with-severe-acute-respiratory-syndrome-coronavirus-2-sars-cov-2/369072/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/co-infections-and-reactivation-of-some-herpesviruses-hhv-and-measles-virus-mev-in-egyptian-cancer-patients-infected-with-severe-acute-respiratory-syndrome-coronavirus-2-sars-cov-2/369072.png","ImageObject",300,407,{"name":42,"@type":43},"moss~","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the primary purpose of the study?","Question",{"text":63,"@type":64},"To investigate the interplay between SARS-CoV-2, HHV, and MeV in cancer patients, providing insights into infection pathophysiology and supporting improved patient health outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were SARS-CoV-2 infections and antibody responses measured?",{"text":68,"@type":64},"SARS-CoV-2 was tested using real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). Antibody responses were analyzed using indirect ELISA.",{"name":70,"@type":61,"acceptedAnswer":71},"What major findings were reported about herpesviruses and measles virus reactivation?",{"text":72,"@type":64},"Herpes simplex viruses 1 and 2 (HSV1/2) showed significantly increased recent infections or re-infection in COVID-19 patients, with HSV1/2 reactivation reported in cancer/COVID-19 patients. MeV IgG levels and MeV reactivation were also higher in cancer patients, including in groups with COVID-19.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369072,1790300975,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Mayla et al.  \nJournal of the Egyptian National Cancer Institute (2025) 37:19  \n[https://doi.org/10.1186/s43046-025-00275-1](https://doi.org/10.1186/s43046-025-00275-1)  \nJournal of the Egyptian National Cancer Institute  \n RESEARCH Open Access  \nCo-infections and Reactivation of some  \nHerpesviruses (HHV) and Measles Virus (MeV) in Egyptian Cancer Patients infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)  \nAhmed M. Mayla 1, Waleed S. Mohamed 1*, Abdel‑Rahman N. Zekri 1, Nora A. Gouda2, Mai M. Lotfy 1, Mohamed G. Seadawy3, Mohamed Abdel‑Salam Elgohary4 and Zeinab F. Abdallah 1  \nAbstract  \nBackground Coinfections and reactivation of persistent or latent viral infections such as herpesviruses (HHV) and/ or measles virus (MeV) have been reported among COVID‑19 patients. However, there is limited information regard‑ ing cancer patients who experienced severe acute respiratory syndrome corona virus‑2 (SARS‑CoV‑2) . The primary purpose of this study was to investigate the interplay between SARS‑CoV‑2, HHV and MeV in cancer patients, aiming to provide insights into the pathophysiology of these infections and to enhance the patients’ health outcomes. Methods A prospective observational study was conducted on 4 groups (n= 147): newly diagnosed cancer patients infected with SARS‑CoV‑2 (n= 37), newly diagnosed cancer patients non‑infected with SARS‑CoV‑2 (n= 13), appar‑ ently normal individuals infected with SARS‑CoV‑2 (n= 82) and finally a normal control group (n= 15) . All samples were tested for SARS‑CoV‑2 infection using the real‑rime quantitative reverse transcription polymerase chain reaction (qRT‑PCR) . Antibody responses were analyzed using indirect enzyme‑linked immunosorbent assay (ELISA), and anti‑ body levels were compared between patients and controls. Potential re‑activation was investigated using fourfold (i. e. 400%) rise model criterion.  \nResults In all positive cases of SARS‑CoV‑2, recent infections or re‑infection of herpes simplex viruses 1 and 2 (HSV1/2 or HHV1‑2) were found to be significantly increased approximately three‑fold higher in COVID‑19 patients (p = 0 . 007) identified via pooled HSV1/2 IgM levels in plasma. Furthermore, reactivation of HSV1/2 was 29. 7% in cancer/COVID‑19 patients (n= 37) versus 0. 0% of normal/COVID‑19 group (n= 22) (p = 0 . 008) . Likewise, Epstein‑Barr Nuclear Antigen‑1 (EBNA‑1) IgG levels showed a ≥fourfold increase in 20%(p = 0 . 034) of cancer patients (n= 50) versus 4. 9% of controls (n= 41) for reactivation of Epstein‑Barr virus (EBV or HHV‑4) . Obviously, MeV IgG levels increased up to 78. 0% in cancer patients (n= 50) versus 17. 5% in non‑cancerous group (n= 40, p \u003C 0. 001) . Reactivation of MeV in cancer and COVID‑19 patients was 43. 2% versus 30. 8% cancer non‑COVID‑19 group, 3. 3% normal COVID‑19, and 0. 0% in healthy volunteers (p \u003C 0. 001) .  \n*Correspondence:  \nWaleed S. Mohamed  \n[waleed.seif@nci.cu.edu.eg](waleed.seif@nci.cu.edu.eg)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/lice","cbCaiuSSKOiKoYLs","https://ap.wps.com/l/cbCaiuSSKOiKoYLs","pdf",1159937,13,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What was the primary purpose of the study?\",\"answer\":\"To investigate the interplay between SARS-CoV-2, HHV, and MeV in cancer patients, providing insights into infection pathophysiology and supporting improved patient health outcomes.\"},{\"question\":\"How were SARS-CoV-2 infections and antibody responses measured?\",\"answer\":\"SARS-CoV-2 was tested using real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). Antibody responses were analyzed using indirect ELISA.\"},{\"question\":\"What major findings were reported about herpesviruses and measles virus reactivation?\",\"answer\":\"Herpes simplex viruses 1 and 2 (HSV1/2) showed significantly increased recent infections or re-infection in COVID-19 patients, with HSV1/2 reactivation reported in cancer/COVID-19 patients. MeV IgG levels and MeV reactivation were also higher in cancer patients, including in groups with COVID-19.\"}]","Co-infections and Reactivation of some Herpesviruses (HHV) and Measles Virus (MeV) in Egyptian Cancer Patients infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | PDF",1790180520,33,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c1a91285d2cda102a00a766bfb9e9ed.webp",983,1305,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e5d5bb4b4cddc402916afca65866d7c1.webp",982,1304,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81464c9703ff8629b94de4ee8885b483.webp",981,1303,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4df6b461f31ae17aca0a9705a7c18741.webp",980,1301]